Trial Profile
A Study to Investigate the Pharmacodynamic Effect of Single Doses of MT-8554 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Apr 2023
Price :
$35
*
At a glance
- Drugs Elismetrep (Primary) ; Oxycodone
- Indications Diabetic neuropathies; Neurological disorders; Vasomotor symptoms
- Focus Pharmacodynamics
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 05 Jan 2016 Status changed from recruiting to completed, as reported by ClinicalTrials.gov record.
- 02 Sep 2015 New trial record